Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
A Agilent Technologies	$117.71 +1.4%	$111.19	$96.43 ▼ $153.84	$32.99B	1.23	1.89 million shs	1.95 million shs
CNC Centene	$54.02 +1.2%	$58.14	$52.93 ▼ $80.59	$26.57B	0.45	4.94 million shs	4.23 million shs
HUM Humana	$238.61 +1.7%	$243.81	$212.45 ▼ $406.46	$28.32B	0.43	1.81 million shs	1.28 million shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
A Agilent Technologies	+1.29%	+1.39%	+8.37%	-1.67%	-12.86%
CNC Centene	+1.09%	-1.63%	-4.27%	-10.83%	-20.61%
HUM Humana	+1.62%	-1.15%	+6.14%	-11.71%	-33.36%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
A Agilent Technologies	4.6268 of 5 stars	3.3	5.0	2.5	3.6	2.1	0.8	1.3
CNC Centene	4.9779 of 5 stars	4.3	5.0	0.0	3.6	2.3	1.7	3.8
HUM Humana	4.4151 of 5 stars	3.2	3.0	2.5	3.9	1.5	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
A Agilent Technologies	2.50	Moderate Buy	$140.92	19.72% Upside
CNC Centene	2.56	Moderate Buy	$77.71	43.87% Upside
HUM Humana	2.30	Hold	$280.76	17.67% Upside

Current Analyst Ratings Breakdown

Latest CNC, HUM, and A Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/24/2025	A Agilent Technologies	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$115.00 ➝ $125.00
6/17/2025	HUM Humana	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$320.00 ➝ $260.00
6/17/2025	HUM Humana	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Hold ➝ Hold	$305.00 ➝ $280.00
6/12/2025	HUM Humana	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Equal Weight ➝ Equal Weight	$273.00 ➝ $268.00
6/9/2025	CNC Centene	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$70.00
6/2/2025	CNC Centene	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Equal Weight	$84.00 ➝ $65.00
6/2/2025	HUM Humana	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$322.00 ➝ $273.00
5/30/2025	A Agilent Technologies	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy	$135.00
5/29/2025	A Agilent Technologies	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$150.00 ➝ $130.00
5/29/2025	A Agilent Technologies	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$160.00 ➝ $155.00
5/29/2025	A Agilent Technologies	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy	$150.00

(Data available from 6/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
A Agilent Technologies	$6.51B	5.14	$6.34 per share	18.58	$21.60 per share	5.45
CNC Centene	$163.07B	0.16	$10.00 per share	5.40	$52.49 per share	1.03
HUM Humana	$117.76B	0.24	$24.27 per share	9.83	$136.57 per share	1.75

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
A Agilent Technologies	$1.29B	$4.05	29.06	19.36	3.53	17.59%	25.92%	13.24%	8/20/2025 (Estimated)
CNC Centene	$3.31B	$6.71	8.05	7.33	0.64	2.04%	14.56%	4.75%	7/25/2025 (Estimated)
HUM Humana	$1.21B	$14.14	16.87	18.17	1.77	1.42%	14.47%	5.03%	7/30/2025 (Estimated)

Latest CNC, HUM, and A Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/28/2025	Q2 2025	A Agilent Technologies	$1.26	$1.31	+$0.05	$0.75	$1.63 billion	$1.67 billion
4/30/2025	Q1 2025	HUM Humana	$10.07	$11.58	+$1.51	$10.30	$32.00 billion	$32.11 billion
4/25/2025	Q1 2025	CNC Centene	$2.52	$2.90	+$0.38	$2.63	$43.16 billion	$46.62 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
A Agilent Technologies	$0.99	0.84%	N/A	24.44%	9 Years
CNC Centene	N/A	N/A	N/A	N/A	N/A
HUM Humana	$3.54	1.48%	N/A	25.04%	N/A

Latest CNC, HUM, and A Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/17/2025	HUM Humana	quarterly	$0.8850	1.24%	6/27/2025	6/27/2025	7/25/2025
5/22/2025	A Agilent Technologies	quarterly	$0.2480	0.9%	7/1/2025	7/1/2025	7/23/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
A Agilent Technologies	0.55	2.09	1.60
CNC Centene	0.65	1.11	1.11
HUM Humana	0.71	1.91	1.91

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
A Agilent Technologies	N/A
CNC Centene	93.63%
HUM Humana	92.38%

Insider Ownership

Company	Insider Ownership
A Agilent Technologies	N/A
CNC Centene	0.36%
HUM Humana	0.37%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
A Agilent Technologies	17,900	284.07 million	N/A	Optionable
CNC Centene	60,500	497.60 million	495.81 million	Optionable
HUM Humana	65,680	120.69 million	120.25 million	Optionable

CNC, HUM, and A Headlines

Recent News About These Companies

Humana Expands Science-Based Targets with New SBTi-Validated Target

June 24 at 11:16 PM | finance.yahoo.com

Humana: Margin Over Volume Signals A Buy

June 24 at 3:57 PM | seekingalpha.com

Invesco LLC Cuts Stock Position in Humana Inc. (NYSE:HUM)

June 24 at 7:23 AM | marketbeat.com

Humana’s Strategic Focus on Clinical Excellence Amid External Uncertainties: A Hold Rating Analysis

June 24 at 5:17 AM | tipranks.com

Humana Inc. (NYSE:HUM) Shares Sold by Kentucky Retirement Systems Insurance Trust Fund

June 24 at 4:16 AM | marketbeat.com

Oz: Insurers' prior auth pledge 'an opportunity for the industry to show itself'

June 23 at 5:15 PM | fiercehealthcare.com

Humana holds investor day on Medicare Advantage

June 23 at 5:15 PM | msn.com

US health chief Kennedy met with insurers on prior authorization requirements

June 23 at 3:06 PM | reuters.com

Manning & Napier Advisors LLC Raises Position in Humana Inc. (NYSE:HUM)

June 23 at 5:05 AM | marketbeat.com

Avantra Family Wealth Inc. Makes New $279,000 Investment in Humana Inc. (NYSE:HUM)

June 22 at 6:46 AM | marketbeat.com

Praxis Investment Management Inc. Has $1.13 Million Holdings in Humana Inc. (NYSE:HUM)

June 22 at 4:40 AM | marketbeat.com

Sivik Global Healthcare LLC Has $6.09 Million Stake in Humana Inc. (NYSE:HUM)

June 21, 2025 | marketbeat.com

Humana plans to reach 4-star Medicare Advantage ratings in 2028

June 20, 2025 | healthcarefinancenews.com

Humana Inc. (NYSE:HUM) Shares Sold by Retirement Systems of Alabama

June 20, 2025 | marketbeat.com

Truist Financial Lowers Humana (NYSE:HUM) Price Target to $280.00

June 19, 2025 | americanbankingnews.com

Humana (NYSE:HUM) Price Target Lowered to $260.00 at Bank of America

June 19, 2025 | americanbankingnews.com

Humana Launches "Invite" Campaign to Inspire Active Aging Through Pickleball and Community Connection

June 18, 2025 | finance.yahoo.com

Humana Launches “Invite” Campaign to Inspire Active Aging Through Pickleball and Community Connection

June 18, 2025 | businesswire.com

Humana’s Strategic Focus and Growth Initiatives Drive Buy Rating and Strong Earnings Potential

June 18, 2025 | tipranks.com

PKO Investment Management Joint Stock Co Decreases Holdings in Humana Inc. (NYSE:HUM)

June 18, 2025 | marketbeat.com

Nurse Managers Claim Humana Violated FLSA, Owes Overtime Pay

June 17, 2025 | news.bloomberglaw.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Industrials Stocks Standing Out for Growth and Analyst Optimism
By Nathan Reiff | June 4, 2025
View 3 Industrials Stocks Standing Out for Growth and Analyst Optimism
3 Catalysts in 7 Days: Archer's Growth Story Just Accelerated
By Jeffrey Neal Johnson | June 18, 2025
View 3 Catalysts in 7 Days: Archer's Growth Story Just Accelerated
Government Mandate Sends eVTOL Stocks Flying
By Jeffrey Neal Johnson | June 10, 2025
View Government Mandate Sends eVTOL Stocks Flying
SoundHound’s AI Growth Story Is Just Getting Started
By Gabriel Osorio-Mazilli | June 16, 2025
View SoundHound’s AI Growth Story Is Just Getting Started
Archer's Midnight Air Taxi Soars, But Stock Doesn’t Budge
By Jeffrey Neal Johnson | June 4, 2025
View Archer's Midnight Air Taxi Soars, But Stock Doesn’t Budge

CNC, HUM, and A Company Descriptions

Agilent Technologies NYSE:A

$117.71 +1.58 (+1.36%)

Closing price 06/24/2025 03:59 PM Eastern

Extended Trading

$117.68 -0.03 (-0.02%)

As of 06/24/2025 07:30 PM Eastern

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Centene NYSE:CNC

$54.02 +0.62 (+1.15%)

Closing price 06/24/2025 03:59 PM Eastern

Extended Trading

$54.02 +0.01 (+0.02%)

As of 06/24/2025 07:57 PM Eastern

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.

Humana NYSE:HUM

$238.61 +3.95 (+1.68%)

Closing price 06/24/2025 03:59 PM Eastern

Extended Trading

$240.24 +1.63 (+0.68%)

As of 04:00 AM Eastern

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time